Search Results for: REL

325 interactions involving REL - REL proto-oncogene, NF-kB subunit found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
ARFIP2 ARF interacting protein 2
  • Retrograde transport at the Trans-Golgi-Network
ARIH2 ariadne RBR E3 ubiquitin protein ligase 2
  • Antigen processing: Ubiquitination & Proteasome degradation
ARL16 ARF like GTPase 16
ARMC7 armadillo repeat containing 7
ARNT2 aryl hydrocarbon receptor nuclear translocator 2
  • PPARA activates gene expression
  • Phase I - Functionalization of compounds
  • Endogenous sterols
  • Xenobiotics
  • Aryl hydrocarbon receptor signalling
  • NPAS4 regulates expression of target genes
  • NPAS4 regulates expression of target genes
ASAP3 ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
ASMTL acetylserotonin O-methyltransferase like
ATG9A autophagy related 9A
  • Macroautophagy
  • PINK1-PRKN Mediated Mitophagy
ATP6V0D2 ATPase H+ transporting V0 subunit d2
  • ROS and RNS production in phagocytes
  • Insulin receptor recycling
  • Transferrin endocytosis and recycling
  • Amino acids regulate mTORC1
  • Ion channel transport
  • Tiludronic acid
ATP6V1C2 ATPase H+ transporting V1 subunit C2
  • ROS and RNS production in phagocytes
  • Insulin receptor recycling
  • Transferrin endocytosis and recycling
  • Amino acids regulate mTORC1
  • Ion channel transport
  • Tiludronic acid
ATPAF2 ATP synthase mitochondrial F1 complex assembly factor 2
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
ATXN1 ataxin 1
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
BANP BTG3 associated nuclear protein
  • Regulation of TP53 Activity through Association with Co-factors
  • Degradation of CDH1
BARHL2 BarH like homeobox 2
BBS4 Bardet-Biedl syndrome 4
  • BBSome-mediated cargo-targeting to cilium
  • Bardet-Biedl syndrome (BBS)
BCL2L15 BCL2 like 15
BCL6 BCL6 transcription repressor
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
  • FOXO-mediated transcription of cell death genes
  • Hairy-cell leukemia
BID BH3 interacting domain death agonist
  • Activation of BAD and translocation to mitochondria
  • Activation and oligomerization of BAK protein
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Activation, translocation and oligomerization of BAX
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
  • Activation, myristolyation of BID and translocation to mitochondria
BLTP2 bridge-like lipid transfer protein family member 2
BMF Bcl2 modifying factor
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Activation of BMF and translocation to mitochondria

Page 2 out of 17 pages